BRIEF-Ackman expects Valeant to grow Bausch & Lomb, Salix products, dermatology

Mon May 2, 2016 1:03pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 2 (Reuters) -

* Ackman says he believes the government will "do its job" regarding Herbalife - CNBC

* Ackman says Herbalife has caused enormous harm and advises that its employees should leave their jobs

* Ackman says with Valeant at $30 per share, the market is saying there is some chance that the company "disappears"

* Ackman says he sees growth for Valeant in its products from Salix acquisition, dermatology and Bausch & Lomb Further company coverage: (Reporting By Caroline Humer)